Drug Therapy for the Elderly (eBook)

Foreword by J. Gurwitz1          General aspects .-1.1        Heterogeneity and vulnerability of older patients(Heinrich Burkhardt) .-1.2        Epidemiological aspects (Heinrich Burkhardt) .-1.3        Age-associated general pharmacological aspects(Martin Wehling) .-1.4            Critical extrapolation of guidelines and study results: risk-benefit-assessment for patients with reduced life expectancy and a new classification of drugs according to their fitness for the aged (Martin Wehling) .-1.5        Inappropriate medication and medication errors in the elderly(Zachary A. Marcum and Joseph T. Hanlon) .- 2            Special aspects with respect to organ systems based on geriatric clinical importance .-2.1        Arterial hypertension (Martin Wehling) .-2.2        Heart failure (Martin Wehling, Robert L. Page 2nd) .-2.3        Coronary heart disease and stroke(Martin Wehling) .-2.4        Atrial fibrillation (Martin Wehling) .-2.5        Diabetes mellitus (Heinrich Burkhardt) .-2.6        Obstructive pulmonary disease(Martin Wehling) .-2.7        Osteoporosis (Martin Wehling) .-2.8        Parkinson’s disease (Heinrich Burkhardt) .-2.9        Therapy of chronic pain (Heinrich Burkhardt) .-2.10        Dementia (Stefan Schwarz, Lutz Frölich) .-2.11        Depression (Stefan Schwarz, Lutz Frölich) .-2.12        Sleep disorders (Stefan Schwarz, Lutz Frölich) .-2.13        Therapy decisions and drug therapy of cancer in the elderly (Ulrich Wedding, Stuart M. Lichtman) .- 3            Pharmacotherapy and geriatric syndromes .-3.1        Fall risk and pharmacotherapy(Heinrich Burkhardt) .-3.2        Central nervous-system (CNS) medications and delirium (Donna M. Fick) .- 3.3       Pharmacotherapy and special aspects of cognitive disorders in the elderly (Heinrich Burkhardt) .-       3.4       Pharmacotherapy and incontinence(Heinrich Burkhardt, J. Mark Ruscin) .-3.5       Immobility and pharmacotherapy (Heinrich Burkhardt) .-3.6       Pharmacotherapy and the frailty syndrome (Heinrich Burkhardt) .- 4            Further problem areas in gerontopharmacotherapy and pragmatic recommendations .-4.1        Adherence to pharmacotherapy in the elderly(Heinrich Burkhardt) .-4.2        Polypharmacy (Heinrich Burkhardt) .-4.3        Inappropriate prescribing in the hospitalized elderly patient (Robert L. Page 2nd, J. Mark Ruscin) .-